Cyanocobalamin as Photosensitizing Agent

Overview

is cyanocobalamin active as Photosensitizing Agent instead of riboflavin ? using cyanocobalamin with mix of external collagen to make crosslinking with cornea collagen to make rigid of cornea

Full Title of Study: “Cyanocobalamin as Photosensitizing Agent Using to Make Cross-linking to Cornea Collagen in Treatment of Progressive Keratoconus”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Retrospective
  • Study Primary Completion Date: September 1, 2023

Clinical Trial Outcome Measures

Primary Measures

  • PRESERVATION of presence of red flare by using slit lamb
    • Time Frame: Base line
    • Cyanocobalamin react with cornea collagen and format red flare

Participating in This Clinical Trial

Inclusion Criteria

  • – Is 20 years or older Has been diagnosed with Keratoconus; Has no other active ocular disease; Is not pregnant or nursing; Exclusion Criteria:

  • Is under the age of 20 Has best corrected visual acuity outside 20/400; Pregnant or nursing at the time of enrollment in the study;

Gender Eligibility: All

Minimum Age: 20 Years

Maximum Age: 40 Years

Investigator Details

  • Lead Sponsor
    • EL Romany Ophthalmics Factory
  • Provider of Information About this Clinical Study
    • Principal Investigator: Mina ibrahim shalalpy, R&D Manger – EL Romany Ophthalmics Factory

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.